Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist
Michael R. McKeown(Howard Hughes Medical Institute), Ravindra Majeti(Stanford University), Matthew G. Guenther(Arsenal Medical (United States)), Matthew L. Eaton(Lypro Biosciences (United States)), Christian Fritz(AVEO Oncology (United States)), Jakob Lovén(AVEO Oncology (United States)), Mei Wei Chen(AVEO Oncology (United States)), Steven M. Chan(Princess Margaret Cancer Centre), Chris Fiore(AVEO Oncology (United States)), Darren Smith(AVEO Oncology (United States)), Jeremy T. Lopez(AVEO Oncology (United States)), Julie L. Koenig(Stanford University), Kathryn Austgen(AVEO Oncology (United States)), Emily Lee(Environmental Law Institute), David A. Orlando(Arsenal Medical (United States)), M. Ryan Corces(Gladstone Institutes)
Cited by 139
Related Papers
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
|Nature Methods|2017|2.8k
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression
|Nature|2011|2k
ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis
|Nature Genetics|2021|1.5k
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.4k